Significant improvement in overall survival among patients diagnosed with low-risk myelodysplastic syndrome treated with selective serotonin reuptake inhibitors

Br J Haematol. 2017 Apr;177(1):142-144. doi: 10.1111/bjh.14031. Epub 2016 Apr 7.
No abstract available

Keywords: cytokine; myelodysplasia; selective serotonin reuptake inhibitor; serotonin..

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Myelodysplastic Syndromes / diagnosis
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / mortality*
  • Proportional Hazards Models
  • Serotonin Uptake Inhibitors / therapeutic use*
  • Survival Rate
  • Treatment Outcome

Substances

  • Serotonin Uptake Inhibitors